{"id":11231,"date":"2024-02-01T12:32:35","date_gmt":"2024-02-01T12:32:35","guid":{"rendered":"https:\/\/cms.alj3.clients.lemonhq.io\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/"},"modified":"2025-12-09T07:22:59","modified_gmt":"2025-12-09T07:22:59","slug":"abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm","status":"publish","type":"inthenews","link":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/","title":{"rendered":"Abdul Latif Jameel Health acquires majority stake in gene therapy pioneer Genpharm"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.arabnews.com\/\">Arab News<\/a> reports on a <a href=\"https:\/\/www.arabnews.com\/node\/2451791\/corporate-news\">new announcement<\/a> that <a href=\"https:\/\/aljhealth.com\/en\/\">Abdul Latif Jameel Health<\/a>, part of Abdul Latif Jameel, has announced its strategic acquisition of a majority stake in <a href=\"https:\/\/www.genpharmservices.com\/\">Genpharm<\/a>, a specialty pharmaceutical marketing and consulting company with market access across the Middle East, North Africa and Turkiye.<\/p>\n\n\n\n<p>It reports:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>The agreement marks a significant milestone for both businesses as they work together in putting patients first, driving healthcare inclusivity and accelerating access to modern medical care for those who need it most.<\/p>\n<\/blockquote>\n\n\n\n<p><span class=\"lt-line-clamp__line\">Arab News, Saudi Arabia\u2019s first English language daily newspaper was founded in 1975 and has become<\/span>&nbsp;<span class=\"lt-line-clamp__line\">the Middle East\u2019s leading English daily.&nbsp;<\/span><\/p>\n","protected":false},"featured_media":4571,"menu_order":0,"template":"","class_list":["post-11231","inthenews","type-inthenews","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Abdul Latif Jameel Health acquires majority stake in gene therapy pioneer Genpharm - Abdul Latif Jameel<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abdul Latif Jameel Health acquires majority stake in gene therapy pioneer Genpharm - Abdul Latif Jameel\" \/>\n<meta property=\"og:description\" content=\"Arab News reports on a new announcement that Abdul Latif Jameel Health, part of Abdul Latif Jameel, has announced its strategic acquisition of a majority stake in Genpharm, a specialty pharmaceutical marketing and consulting company with market access across the Middle East, North Africa and Turkiye. It reports: The agreement marks a significant milestone for [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/\" \/>\n<meta property=\"og:site_name\" content=\"Abdul Latif Jameel\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-09T07:22:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1738\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/\",\"url\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/\",\"name\":\"Abdul Latif Jameel Health acquires majority stake in gene therapy pioneer Genpharm - Abdul Latif Jameel\",\"isPartOf\":{\"@id\":\"https:\/\/10.0.2.222\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg\",\"datePublished\":\"2024-02-01T12:32:35+00:00\",\"dateModified\":\"2025-12-09T07:22:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/#primaryimage\",\"url\":\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg\",\"contentUrl\":\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg\",\"width\":2560,\"height\":1738},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/10.0.2.222\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abdul Latif Jameel Health acquires majority stake in gene therapy pioneer Genpharm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/10.0.2.222\/en\/#website\",\"url\":\"https:\/\/10.0.2.222\/en\/\",\"name\":\"Abdul Latif Jameel\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/10.0.2.222\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abdul Latif Jameel Health acquires majority stake in gene therapy pioneer Genpharm - Abdul Latif Jameel","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Abdul Latif Jameel Health acquires majority stake in gene therapy pioneer Genpharm - Abdul Latif Jameel","og_description":"Arab News reports on a new announcement that Abdul Latif Jameel Health, part of Abdul Latif Jameel, has announced its strategic acquisition of a majority stake in Genpharm, a specialty pharmaceutical marketing and consulting company with market access across the Middle East, North Africa and Turkiye. It reports: The agreement marks a significant milestone for [&hellip;]","og_url":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/","og_site_name":"Abdul Latif Jameel","article_modified_time":"2025-12-09T07:22:59+00:00","og_image":[{"width":2560,"height":1738,"url":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/","url":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/","name":"Abdul Latif Jameel Health acquires majority stake in gene therapy pioneer Genpharm - Abdul Latif Jameel","isPartOf":{"@id":"https:\/\/10.0.2.222\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/#primaryimage"},"image":{"@id":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/#primaryimage"},"thumbnailUrl":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg","datePublished":"2024-02-01T12:32:35+00:00","dateModified":"2025-12-09T07:22:59+00:00","breadcrumb":{"@id":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/#primaryimage","url":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg","contentUrl":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg","width":2560,"height":1738},{"@type":"BreadcrumbList","@id":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/in-the-news\/abdul-latif-jameel-health-acquires-majority-stake-in-gene-therapy-pioneer-genpharm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/10.0.2.222\/en\/"},{"@type":"ListItem","position":2,"name":"Abdul Latif Jameel Health acquires majority stake in gene therapy pioneer Genpharm"}]},{"@type":"WebSite","@id":"https:\/\/10.0.2.222\/en\/#website","url":"https:\/\/10.0.2.222\/en\/","name":"Abdul Latif Jameel","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/10.0.2.222\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"post-meta-fields":{"_wp_page_template":["default"],"_published_date":["field_6057129b493f5"],"published_date":["20240201"],"_location":["field_601267396ce72"],"location":[""],"_featured":["field_601a3b473c5c5"],"featured":[""],"_footnotes":["field_66fd39afb9383"],"footnotes":[""],"_business_sector":["field_66f6b5bcac8cb"],"business_sector":["Health"],"_content_series":["field_66fe3c439f8f6"],"content_series":[""],"_old_post_id":["field_66fe3fd59f8f7"],"old_post_id":["113711"],"_short_title":["field_60925d67125ef"],"short_title":["Abdul Latif Jameel Health acquires majority stake in Genpharm"],"_summary":["field_6711d2045cf9b"],"summary":["Arab News reports on a new announcement that Abdul Latif Jameel Health, part of Abdul Latif Jameel, a nearly 80-year-old internationally diversified business, has announced its strategic acquisition of a majority stake in Genpharm, a specialty pharmaceutical marketing and consulting company with market access across the Middle East, North Africa and Turkiye."],"_mobile_featured_image":["field_66f6b4bee65f3"],"mobile_featured_image":["https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Untitled-1-1.jpg"],"_push_notification":["field_66f6b47de65f1"],"push_notification":[""],"_publish_mobile":["field_66f6b491e65f2"],"publish_mobile":[""],"_article_source_name":["field_67064f726fd04"],"article_source_name":["Arab News"],"_article_source_url":["field_67064fce6fd05"],"article_source_url":["https:\/\/www.arabnews.com\/node\/2451791\/corporate-news"],"_article_source_data":["field_67064fee6fd06"],"article_source_data":["January 31, 2024"],"_article_listing_image":["field_6711d295c77f5"],"article_listing_image":["16695"],"_status":["field_652694983fe12"],"status":["publish"],"_thumbnail_id":["4571"],"_wpml_word_count":["{\"total\":127,\"to_translate\":{\"ar\":127,\"zh-hans\":127,\"fr\":127,\"ja\":127,\"es\":127,\"tr\":127}}"],"_wpml_location_migration_done":["1"],"_article_source_date":["field_6711d287c77f4"],"article_source_date":["January 31, 2024"],"_edit_lock":["1765514823:12"],"amazonS3_cache":["a:12:{s:78:\"\/\/cms.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/DJI_0066-scaled-1.jpg\";a:2:{s:2:\"id\";s:4:\"4054\";s:11:\"source_type\";s:13:\"media-library\";}s:80:\"\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/DJI_0066-scaled-1.jpg\";a:2:{s:2:\"id\";s:4:\"4054\";s:11:\"source_type\";s:13:\"media-library\";}s:64:\"\/\/cms.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/FRV.png\";a:2:{s:2:\"id\";s:4:\"8849\";s:11:\"source_type\";s:13:\"media-library\";}s:72:\"\/\/cms.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/FRV-150x150.png\";a:2:{s:2:\"id\";s:4:\"8849\";s:11:\"source_type\";s:13:\"media-library\";}s:66:\"\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/FRV.png\";a:2:{s:2:\"id\";s:4:\"8849\";s:11:\"source_type\";s:13:\"media-library\";}s:74:\"\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/FRV-150x150.png\";a:2:{s:2:\"id\";s:4:\"8849\";s:11:\"source_type\";s:13:\"media-library\";}s:102:\"\/\/cms.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Lexus-LM350h_Ataturk-Evi_Selanik-1-scaled.jpg\";a:2:{s:2:\"id\";s:4:\"8882\";s:11:\"source_type\";s:13:\"media-library\";}s:104:\"\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Lexus-LM350h_Ataturk-Evi_Selanik-1-scaled.jpg\";a:2:{s:2:\"id\";s:4:\"8882\";s:11:\"source_type\";s:13:\"media-library\";}s:119:\"\/\/cms.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Lexus-LM350h-ile-Hostes-ve-Pilotlarla-karsilama-yaparken-a.jpg\";a:2:{s:2:\"id\";s:4:\"8881\";s:11:\"source_type\";s:13:\"media-library\";}s:121:\"\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Lexus-LM350h-ile-Hostes-ve-Pilotlarla-karsilama-yaparken-a.jpg\";a:2:{s:2:\"id\";s:4:\"8881\";s:11:\"source_type\";s:13:\"media-library\";}s:79:\"\/\/cms.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Lexus-LM350h-Award.jpg\";a:2:{s:2:\"id\";s:4:\"8880\";s:11:\"source_type\";s:13:\"media-library\";}s:81:\"\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Lexus-LM350h-Award.jpg\";a:2:{s:2:\"id\";s:4:\"8880\";s:11:\"source_type\";s:13:\"media-library\";}}"],"_select_category":["field_6937c5cade1ee"],"select_category":["international"]},"_links":{"self":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/wp-json\/wp\/v2\/inthenews\/11231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/wp-json\/wp\/v2\/inthenews"}],"about":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/wp-json\/wp\/v2\/types\/inthenews"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/wp-json\/wp\/v2\/media\/4571"}],"wp:attachment":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/wp-json\/wp\/v2\/media?parent=11231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}